Co-Diagnostics Intends to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance
Co-Diagnostics has withdrawn its 510(k) application for its Co-Dx PCR COVID-19 Test in favor of submitting an enhanced version.
Read MorePosted by Chris Wolski | Feb 21, 2025 | Covid 19 |
Co-Diagnostics has withdrawn its 510(k) application for its Co-Dx PCR COVID-19 Test in favor of submitting an enhanced version.
Read MorePosted by Chris Wolski | Feb 11, 2025 | POC Instruments |
Researchers developed a portable, at-home, wireless device that simultaneously detects SARS-CoV-2 and vitamin C levels.
Read MorePosted by Chris Wolski | Feb 7, 2025 | Gastrointestinal Infections |
Nearly 50 million Americans, particularly in rural areas, face barriers to seeing a gastroenterologist, needing to travel at least 25 miles.
Read MorePosted by Chris Wolski | Feb 7, 2025 | Company News |
Summary:BD (Becton, Dickinson and Company) announced its plan to separate its Biosciences and...
Read MorePosted by Andy Lundin | Feb 4, 2025 | Kidney Disease, Point-of-Care |
Carna Health is revolutionizing CKD detection by integrating AI-driven analytics with real-time, point-of-care (POC) testing.
Read More